AccessibilityHelpAbout Us
Cyanotech logo

Cyanotech(OTC) CYAN

Market Cap$3.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)-51%
5 YearN/A
1 Year+85%
1 Month+4%
$0.51
+5.00%
+0.02Today
Cyanotech last closing stock price
MetricPriceDate
Last closeUSD 0.512026-09-15
Cyanotech stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.43%USD 0.512026-09-08
1 month+4.08%USD 0.492026-08-14
3 month+30.77%USD 0.392026-06-16
Year to date+13.33%USD 0.452025-12-31
1 year+85.45%USD 0.282025-09-15
Since inception-51.43%USD 1.001990-10-24

Cyanotech Financials at a Glance

Market Cap

$3.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$27.23M

Net Income (TTM)

-$69.00K

EPS (TTM)

-$0.01

P/E Ratio

-56.67

Dividend

$0.00

Beta (Volatility)

0.25 (Low)

Price

$0.51

Volume

6,617

Open

$0.51

Previous Close

$0.51

Daily Range

$0.51 - $0.51

52-Week Range

$0.23 - $0.57

Estimated Earnings Date

Feb 9, 2026

CYAN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cyanotech

Cyanotech Corporation is a leader in the cultivation, processing, and distribution of natural products derived from microalgae. Established in 1983 and based in Kailua-Kona, Hawaii, the company specializes in health-focused products, including dietary supplements that promote overall wellness.

Products and Services
  • BioAstin Hawaiian Astaxanthin, a potent antioxidant for skin and immune health
  • Hawaiian Spirulina Pacifica, a nutrient-rich supplement for energy and cardiovascular support
  • Contract extraction services for health food and nutraceutical industries
Growth Outlook
  • Recent quarterly revenue of $6.47 million shows a strong demand for products
  • Gross profit margin improved to 42.38% in the latest quarter
  • Expansion into online sales channels enhances market reach and customer access
Financial Highlights
  • Trailing twelve months revenue of $28.5 million indicates steady growth
  • Net income of $288,000 in the latest quarter reflects positive operational performance
  • Current ratio of 1.06 suggests adequate liquidity to meet short-term obligations
Cyanotech Corporation has established itself as a significant player in the packaged foods industry, particularly in the health supplement sector. The company's focus on high-quality, natural products positions it well to capitalize on the growing consumer trend towards health and wellness. Recent financial performance indicates a positive trajectory, with increasing revenues and improving profit margins. The strategic expansion into diverse sales channels, including online platforms, further enhances growth potential. Investors may find Cyanotech's commitment to innovation and quality appealing as the company continues to navigate the evolving market landscape.
AI Generated • Sep 2, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

83

CEO

Matthew K. Custer

Website

www.cyanotech.com

Headquarters

Kailua-Kona, HI 96740, US

CYAN Financials

Key Financial Metrics (TTM)

Gross Margin

35.41%

Operating Margin

2.28%

Net Income Margin

-0.25%

Return on Equity

-0.87%

Return on Capital

-2.98%

Return on Assets

-0.32%

Earnings Yield

-1.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.39M

Volume

6.62K

Avg. Volume

2.63K

Financials (TTM)

Gross Profit

$9.64M

Operating Income

$621.00K

EBITDA

$3.38M

Operating Cash Flow

$146.00K

Capital Expenditure

-$229.00K

Free Cash Flow

-$83.00K

Cash & ST Invst.

$1.09M

Total Debt

$11.37M

Cyanotech Performance Analysis

Cyanotech annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 23,178,000-35.6%
20242024-03-31USD 23,071,000-0.5%
20252025-03-31USD 24,215,0005.0%
20262026-03-31USD 26,587,0009.8%
Cyanotech sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3019.9%
Q32025-12-31-15.8%
Q42026-03-3134.6%
Q12026-06-30-18.3%
Cyanotech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.55N/A
20242024-03-31USD -0.8146.4%
20252025-03-31USD -0.45-43.8%
20262026-03-31USD -0.18-61.3%
Cyanotech sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30100.1%
Q32025-12-31-31200.0%
Q42026-03-3143.1%
Q12026-06-30323.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$6.47M

+11.1%

Gross Profit

$2.74M

+54.6%

Gross Margin

42.38%

N/A

Market Cap

$3.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$45.42K

N/A

Employees

83

N/A

Net Income

$288.00K

+131.1%

EBITDA

$845.00K

+427.5%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$1.09M

+185.6%

Total Debt

$11.37M

-4.6%

Accounts Receivable

$2.23M

+42.9%

Inventory

$6.99M

-13.9%

Long Term Debt

$3.60M

-14.6%

Short Term Debt

$7.77M

+0.9%

Return on Assets

-0.32%

N/A

Return on Invested Capital

5.36%

N/A

Free Cash Flow

$364.00K

+136.7%

Operating Cash Flow

$423.00K

+145.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CMGHFChaoda Modern Agriculture (Holdings) Limited
$0.03+0.00%
RSAURooshine, Inc.
$0.23+0.00%
PLVFFPlant Veda Foods Ltd.
$0.06+0.00%
APRUApple Rush Company, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
RETOReTo Eco-Solutions
$14.24+408.57%
INTCIntel
$101.27+4.25%
SPCXSpace Exploration Technologies
$151.28+5.43%
NOKNokia
$10.18+3.44%

Questions About CYAN

What is the current price of Cyanotech?

Cyanotech is trading at $0.51 per share.

What is the 52-week range for Cyanotech?

Over the past 52 weeks, Cyanotech has traded between $0.23 and $0.57.

How much debt does Cyanotech have?

As of the most recent reporting period, Cyanotech reported total debt of $11.37M.

How much cash does Cyanotech have on hand?

Cyanotech reported $1.09M in cash and cash equivalents in its most recent financial results.

What is Cyanotech’s dividend yield?

Cyanotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services